TMS Nearby

Spravato (Esketamine) in Maumelle, Arkansas

Compare 2 Spravato (Esketamine) clinics in Maumelle, Arkansas that offer care for treatment-resistant depression and major depressive disorder. Review services, ratings, and contact details to find the right provider near you.
Mental health clinic illustration

Clinics

2 clinics shown

  • Dr. David C. Haas

    Dr. David C. Haas operates a psychiatric practice in Maumelle, located on Club Manor Drive. The practice provides psychiatric evaluations and medication management for adults. Specific treatment modalities such as TMS, esketamine, or ketamine therapy are not detailed in available information; prospective patients should contact the office to confirm services offered beyond standard psychiatric care.

    No reviews yet
    View Details
  • Dr. Marian Smith

    Dr. Marian Smith operates a psychology practice in Maumelle, located on Club Manor Drive. The practice provides psychological services for adults and adolescents, with a focus on therapy and behavioral health interventions. Specific treatment modalities such as TMS, ketamine, or esketamine are not listed among the clinic's offerings; patients seeking those procedural treatments should confirm availability directly. The practice is part of Comprehensive Psychological Testing and serves the greater Little Rock metropolitan area.

    No reviews yet
    View Details

About Spravato (Esketamine)

Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.

Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.

Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.

The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.

Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.